Broncus Completes First Case of Registered Clinical Trials for Targeted Lung Denervation Radiofrequency Ablation System

Broncus Holding Corporation (HKG:2216) has successfully completed the first case of registered clinical trials for its targeted lung denervation radiofrequency ablation system. The trial, led by Professor Luo Fengming at the West China Hospital of Sichuan University, is a multi-center study aimed at evaluating the safety and effectiveness of Broncus' denervation ablation system in treating Chron..